ACTIVE

Alpha pharma

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

120,6 k €

+5.4% YoY

Gross margin

352,5 k €

+14.2% YoY

Equity

627,1 k €

+10.2% YoY

Workforce

2,2 ETP

+37.5% YoY

What does Alpha pharma do?

Alpha pharma is a Private limited company incorporated in 2014. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Roeselare. It employs on average 2,2 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0544.737.350

Incorporation

17/01/2014

Legal form

Private limited company

Registered office

Oekensestraat 140B
8800 Roeselare · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Average workforce

2,2 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 12 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014
Income statement
Gross margin	352,5 k €	+14.2%	308,6 k €	-16.5%	369,4 k €	+13.2%	326,5 k €	-6.3%	348,4 k €	+41.0%	247 k €	+27.3%	194,1 k €	+9.8%	176,8 k €	+0.9%	175,2 k €	-3.4%	181,3 k €	-6.8%	194,7 k €	+56.4%	124,5 k €
EBITDA	208,3 k €	-1.3%	211,1 k €	-21.4%	268,5 k €	-3.5%	278,3 k €	-11.1%	313 k €	+49.6%	209,3 k €	+19.3%	175,4 k €	+1.2%	173,3 k €	+130%	75,3 k €	-57.5%	177,1 k €	-8.2%	193 k €	+55.9%	123,7 k €
Operating result	160 k €	-0.6%	161 k €	-15.5%	190,4 k €	-3.8%	197,8 k €	-15.8%	234,9 k €	+78.9%	131,3 k €	+29.9%	101,1 k €	+0.3%	100,8 k €	+1110%	8,3 k €	-91.9%	103,5 k €	-31.9%	152 k €	+84.7%	82,3 k €
Net result	120,6 k €	+5.4%	114,4 k €	-17.6%	138,8 k €	+15.2%	120,5 k €	-29.5%	170,8 k €	+108%	82 k €	+27.3%	64,4 k €	-10.5%	71,9 k €	+2130%	-3,5 k €	-106%	63,1 k €	-24.1%	83,1 k €	+166%	31,2 k €
Balance sheet
Equity	627,1 k €	+10.2%	569 k €	+25.2%	454,6 k €	+43.9%	315,8 k €	-44.8%	572,5 k €	+42.5%	401,7 k €	+25.6%	319,7 k €	+25.2%	255,3 k €	+39.2%	183,4 k €	-1.9%	187 k €	+50.9%	123,9 k €	+149%	49,8 k €
Total assets	1,5 M €	+16.5%	1,2 M €	+4.2%	1,2 M €	-3.9%	1,2 M €	-11.7%	1,4 M €	+1.7%	1,4 M €	+2.5%	1,4 M €	+3.1%	1,3 M €	-4.8%	1,4 M €	+49.6%	922 k €	+7.5%	858,1 k €	+3.1%	832,5 k €
Cash	168,3 k €	-3.7%	174,7 k €	+46.5%	119,2 k €	-9.1%	131,1 k €	-44.0%	234 k €	+102%	115,7 k €	+62.3%	71,3 k €	-13.2%	82,1 k €	+80.7%	45,4 k €	-19.8%	56,6 k €	-79.4%	274,5 k €	-11.1%	308,7 k €
Debts	827,7 k €	+21.8%	679,6 k €	-8.6%	743,7 k €	-20.2%	931,5 k €	+11.6%	834,8 k €	-14.9%	980,7 k €	-4.7%	1 M €	-2.1%	1,1 M €	-11.6%	1,2 M €	+63.2%	728,8 k €	+0.4%	725,6 k €	-5.0%	763,9 k €
Other
Workforce	2,2 ETP	+37.5%	1,6 ETP	-15.8%	1,9 ETP	+72.7%	1,1 ETP	+22.2%	0,9 ETP	0.0%	0,9 ETP	+80.0%	0,5 ETP		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 16 ended

Active mandates

Director · 0786.826.188

Represented by Johanna Princen

Active

Ended mandates

Director · since 31 août 2024 · 0786.826.188

Represented by Johanna Princen

Ended

Bert Princen

Director · since 01 septembre 2016

Ended

Bert Princen

Manager · since 01 septembre 2016

Ended

Johanna Princen

Director · since 01 avril 2015

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	23/06/2026	18/07/2025	08/08/2024	22/06/2023	31/08/2022	26/08/2021
General meeting	19/06/2026	20/06/2025	21/06/2024	16/06/2023	31/07/2022	31/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

12 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	19/06/2026	23/06/2026	Dutch	PDF
Abridged model	31/12/2024	20/06/2025	18/07/2025	Dutch	PDF
Abridged model	31/12/2023	21/06/2024	08/08/2024	Dutch	PDF
Abridged model	31/12/2022	16/06/2023	22/06/2023	Dutch	PDF
Abridged model	31/12/2021	31/07/2022	31/08/2022	Dutch	PDF
Abridged model	31/12/2020	31/07/2021	26/08/2021	Dutch	PDF
Abridged model	31/12/2019	08/10/2020	12/10/2020	Dutch	PDF
Abridged model	31/12/2018	30/06/2019	29/07/2019	Dutch	PDF
Abridged model	31/12/2017	31/07/2018	23/08/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	31/07/2017	Dutch	PDF
Abridged model	31/12/2015	31/07/2016	30/08/2016	Dutch	PDF
Abridged model	31/12/2014	19/06/2015	04/08/2015	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 16 ended

Active mandates

Director · 0786.826.188

Represented by Johanna Princen

Active

Ended mandates

Director · since 31 août 2024 · 0786.826.188

Represented by Johanna Princen

Ended

Bert Princen

Director · since 01 septembre 2016

Ended

Bert Princen

Manager · since 01 septembre 2016

Ended

Johanna Princen

Director · since 01 avril 2015

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates02/10/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/11/2022
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Registered office05/09/2018
MAATSCHAPPELIJKE ZETEL
PDF
Mandates25/11/2016
ONTSLAGEN - BENOEMINGEN
PDF
Other03/11/2016
DIVERSEN
PDF
Mandates08/05/2015
ONTSLAGEN - BENOEMINGEN
PDF
Other04/02/2014
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025120,6 k €↑
2024
Annual accounts 2024114,4 k €↓
2024
Name changeALPHA PHARMA
2023
Annual accounts 2023138,8 k €↑
2022
Annual accounts 2022120,5 k €↓
2021
Annual accounts 2021170,8 k €↑
2020
Annual accounts 202082 k €↑
2019
Annual accounts 201964,4 k €↓
2018
Annual accounts 201871,9 k €↑
2017
Annual accounts 2017-3,5 k €↓
2016
Annual accounts 201663,1 k €↓
2015
Annual accounts 201583,1 k €↑
2014
Annual accounts 201431,2 k €
17/01/2014
IncorporationPrivate limited company
2014
Name changeAPOTHEEK PRINCEN

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Alpha pharma

Overview

What does Alpha pharma do?

Trend over 12 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline